SPC407
Dífelíkefalín á öllum formum sem vernduð eru af grunneinkaleyfinu
Status:
UmsóknApplication date:
18.10.2022Application published:
15.11.2022
Max expiry date:
11.11.2032Medicine name:
KapruviaMedicine for children:
No
Timeline
Today
18.10.2022Application
15.11.2022Publication
11.11.2032Expires
Marketing license
IS authorization number:
EU/1/22/1643/001-002Date:
11.5.2022
Foreign authorization number:
EU/1/22/1643Date:
25.4.2022
Owner
Name:
Vifor Fresenius Medical Care Renal Pharma Ltd.Address:
Rechenstrasse 37, St. Gallen CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2064228